130 related articles for article (PubMed ID: 37931687)
1. Predictive capacity of FAT1 transcriptional expression in patients with head and neck squamous cell carcinomas treated with radiotherapy.
León X; Llansana A; Pérez-Ugarte L; García J; Valero C; Quer M; Camacho M
Acta Otorrinolaringol Esp (Engl Ed); 2023; 74(6):359-364. PubMed ID: 37931687
[TBL] [Abstract][Full Text] [Related]
2. Predictive capacity of IL-8 expression in head and neck squamous carcinoma patients treated with radiotherapy or chemoradiotherapy.
León X; García J; Farré N; Majercakova K; Avilés-Jurado FX; Quer M; Camacho M
Acta Otorrinolaringol Esp (Engl Ed); 2021; 72(6):337-343. PubMed ID: 34844671
[TBL] [Abstract][Full Text] [Related]
3. Predictive capacity of IL-8 expression in head and neck squamous carcinoma patients treated with radiotherapy or chemoradiotherapy.
León X; García J; Farré N; Majercakova K; Avilés-Jurado FX; Quer M; Camacho M
Acta Otorrinolaringol Esp (Engl Ed); 2020 Sep; ():. PubMed ID: 32972719
[TBL] [Abstract][Full Text] [Related]
4. Predictive value of transcriptional expression of Krüppel-like factor-6 (KLF6) in head and neck carcinoma patients treated with radiotherapy.
León X; Venegas M; Pujol A; Bulboa C; Llansana A; Casasayas M; Quer M; Camacho M
Clin Transl Oncol; 2021 Dec; 23(12):2507-2512. PubMed ID: 34061320
[TBL] [Abstract][Full Text] [Related]
5. Relationship between the transcriptional expression of PIM1 and local control in patients with head and neck squamous cell carcinomas treated with radiotherapy.
León X; García J; Pujol A; de Juan J; Vásquez R; Quer M; Camacho M
Eur Arch Otorhinolaryngol; 2022 Jul; 279(7):3679-3684. PubMed ID: 34993612
[TBL] [Abstract][Full Text] [Related]
6. Clinical significance of FAT1 gene mutation and mRNA expression in patients with head and neck squamous cell carcinoma.
Kim SI; Woo SR; Noh JK; Lee MK; Lee YC; Lee JW; Ko SG; Eun YG
Mol Oncol; 2022 Apr; 16(8):1661-1679. PubMed ID: 34939311
[TBL] [Abstract][Full Text] [Related]
7. FAT1 somatic mutations in head and neck carcinoma are associated with tumor progression and survival.
Lin SC; Lin LH; Yu SY; Kao SY; Chang KW; Cheng HW; Liu CJ
Carcinogenesis; 2018 Dec; 39(11):1320-1330. PubMed ID: 30102337
[TBL] [Abstract][Full Text] [Related]
8. The Proteomic Landscape of Growth Factor Signaling Networks Associated with
Chen Z; Zhang C; Chen J; Wang D; Tu J; Van Waes C; Saba NF; Chen ZG; Chen Z
Cancer Res; 2021 Sep; 81(17):4402-4416. PubMed ID: 34167951
[TBL] [Abstract][Full Text] [Related]
9. Prognostic capacity of the transcriptional expression of lactate dehydrogenase A in patients with head and neck squamous cell carcinoma.
Bagué S; León X; Terra X; Lejeune M; Camacho M; Avilés-Jurado FX
Head Neck; 2022 Nov; 44(11):2505-2512. PubMed ID: 36207788
[TBL] [Abstract][Full Text] [Related]
10. Prognostic capacity of PIV (pan-immune-inflammation value) in patients with head and neck squamous cell carcinoma.
Sansa A; Valero C; Pujol A; Sauter B; Gayà J; Quer M; León X
Acta Otorrinolaringol Esp (Engl Ed); 2024; 75(2):94-101. PubMed ID: 38220048
[TBL] [Abstract][Full Text] [Related]
11. Association between FAT1 mutation and overall survival in patients with human papillomavirus-negative head and neck squamous cell carcinoma.
Kim KT; Kim BS; Kim JH
Head Neck; 2016 Apr; 38 Suppl 1(Suppl 1):E2021-9. PubMed ID: 26876381
[TBL] [Abstract][Full Text] [Related]
12. Conjoint analysis of OPRPN and SMR3A protein expression as potential predictive biomarkers for head and neck squamous cell carcinoma after radiotherapy.
Rong C; Grünow J; Thierauf J; Lucena-Porcel C; Major G; Holzinger D; Dyckhoff G; Kern J; Lammert A; Scherl C; Rotter N; Plinkert PK; Affolter A
Oncol Rep; 2022 Sep; 48(3):. PubMed ID: 35856431
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of transcriptional expression of fibronectin type III domain-containing 4 (FNDC4) in head and neck carcinoma patients treated with chemoradiotherapy.
Camacho M; León X; Pujol A; Montezuma L; Quer M; García J
Clin Transl Oncol; 2022 Nov; 24(11):2175-2180. PubMed ID: 35752749
[TBL] [Abstract][Full Text] [Related]
14. The value of primary and adjuvant radiotherapy for cutaneous squamous cell carcinomas of the head-and-neck region in the elderly.
Haehl E; Rühle A; Klink R; Kalckreuth T; Sprave T; Gkika E; Zamboglou C; Meiß F; Grosu AL; Nicolay NH
Radiat Oncol; 2021 Jun; 16(1):105. PubMed ID: 34118984
[TBL] [Abstract][Full Text] [Related]
15. Salvage Surgery for Recurrence after Radiotherapy for Squamous Cell Carcinoma of the Head and Neck.
Elbers JBW; Al-Mamgani A; van den Brekel MWM; Jóźwiak K; de Boer JP; Lohuis PJFM; Willems SM; Verheij M; Zuur CL
Otolaryngol Head Neck Surg; 2019 Jun; 160(6):1023-1033. PubMed ID: 30526317
[TBL] [Abstract][Full Text] [Related]
16. TP53 mutation is related to poor prognosis after radiotherapy, but not surgery, in squamous cell carcinoma of the head and neck.
Alsner J; Sørensen SB; Overgaard J
Radiother Oncol; 2001 May; 59(2):179-85. PubMed ID: 11325447
[TBL] [Abstract][Full Text] [Related]
17. Radioresistance and genomic alterations in head and neck squamous cell cancer: Sub-analysis of the ProfiLER protocol.
Rowinski E; Magné N; Fayette J; Daguenet E; Racadot S; Pommier P; Méry B; Vallard A; Tinquaut F; Neidhardt-Berard EM; Cassier P; Attignon V; Pissaloux D; Wang Q; Sohier E; Pérol D; Blay JY; Trédan O
Head Neck; 2021 Dec; 43(12):3899-3910. PubMed ID: 34643313
[TBL] [Abstract][Full Text] [Related]
18. Relationship between tumour cell in vitro radiosensitivity and clinical outcome after curative radiotherapy for squamous cell carcinoma of the head and neck.
Stausbøl-Grøn B; Overgaard J
Radiother Oncol; 1999 Jan; 50(1):47-55. PubMed ID: 10225557
[TBL] [Abstract][Full Text] [Related]
19. Low cytoplasmic and nuclear KPNA2 expression in radiotherapy-treated head and neck squamous cell cancer is associated with an adverse outcome.
Erben PB; Brunner K; Hecht M; Haderlein M; Büttner-Herold M; Agaimy A; Fietkau R; Hartmann A; Distel LV
Int J Clin Exp Pathol; 2015; 8(12):15814-24. PubMed ID: 26884852
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of CD45 transcriptional expression in head and neck cancer.
Camacho M; Agüero A; Sumarroca A; López L; Pavón MÁ; Avilés-Jurado FX; García J; Quer M; León X
Eur Arch Otorhinolaryngol; 2018 Jan; 275(1):225-232. PubMed ID: 29177949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
